Bausch Health Companies Inc.

NYSE:BHC Voorraadrapport

Marktkapitalisatie: US$3.2b

Bausch Health Companies Toekomstige groei

Future criteriumcontroles 3/6

De verwachting is dat Bausch Health Companies de winst en omzet met respectievelijk 218.3% en 1.5% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 222.8% per jaar.

Belangrijke informatie

218.3%

Groei van de winst

222.8%

Groei van de winst per aandeel

Pharmaceuticals winstgroei24.0%
Inkomstengroei1.5%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Good

Laatst bijgewerkt02 Nov 2024

Recente toekomstige groei-updates

Recent updates

There's No Escaping Bausch Health Companies Inc.'s (NYSE:BHC) Muted Revenues Despite A 28% Share Price Rise

Oct 10
There's No Escaping Bausch Health Companies Inc.'s (NYSE:BHC) Muted Revenues Despite A 28% Share Price Rise

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

Sep 19

Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

Aug 06
Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

2 Red Alerts On Bausch Health Companies

Jul 25

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation

Feb 24

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Nov 30

Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Nov 01
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics

Sep 24

Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Jul 24
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes

Jul 06

What To Do After Bausch Health Stock Plunged By Nearly 9% Again

Jun 07

Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Apr 18
Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out

Dec 30

Bausch Health acne lotion Arazlo available in Canada under public drug plans

Dec 22

Bausch Health: Things To Consider Before Investing

Dec 11

Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Nov 10
Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Bausch Health Companies Q3 2022 Earnings Preview

Nov 02

Bausch Health: Long-Term Need To Place Stops For Protection

Sep 28

Winst- en omzetgroeiprognoses

NYSE:BHC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202610,249N/A2,8601,2805
12/31/20259,9044052,0261,5357
12/31/20249,573-556501,2877
9/30/20249,474-1781,0091,386N/A
6/30/20249,202-4719111,263N/A
3/31/20248,966-4557851,089N/A
12/31/20238,757-5927601,032N/A
9/30/20238,542-9638931,117N/A
6/30/20238,350-186-665-428N/A
3/31/20238,150-357-773-511N/A
12/31/20228,124-225-996-728N/A
9/30/20228,127254-1,434-1,179N/A
6/30/20228,19243384648N/A
3/31/20228,325-407648920N/A
12/31/20218,434-9481,1431,426N/A
9/30/20218,451-1,1701,5121,796N/A
6/30/20218,478-1,2871,1901,488N/A
3/31/20218,042-1,0189881,293N/A
12/31/20208,027-5608021,111N/A
9/30/20208,038-1,923641951N/A
6/30/20208,109-2,0438991,210N/A
3/31/20208,597-1,8881,0461,349N/A
12/31/20198,601-1,7881,2231,501N/A
9/30/20198,498-6161,3291,586N/A
6/30/20198,425-9171,3861,593N/A
3/31/20198,401-1,6191,2411,476N/A
12/31/20188,380-4,1481,2661,501N/A
9/30/20188,422-3,2911,5171,760N/A
6/30/20188,505-1,640N/A1,728N/A
3/31/20188,610-805N/A1,774N/A
12/31/20178,7242,404N/A2,290N/A
9/30/20178,9641,376N/A2,224N/A
6/30/20179,224-1,143N/A2,304N/A
3/31/20179,411-1,407N/A2,484N/A
12/31/20169,674-2,409N/A2,087N/A
9/30/201610,024-2,280N/A2,172N/A
6/30/201610,332-1,013N/A2,360N/A
3/31/201610,644-764N/A2,323N/A
12/31/201510,442-292N/A2,257N/A
9/30/20159,906596N/A2,476N/A
6/30/20159,175822N/A2,336N/A
3/31/20158,4841,001N/A2,302N/A
12/31/20148,200881N/A2,312N/A
9/30/20148,043502N/A1,759N/A
6/30/20147,529-746N/A1,342N/A
3/31/20146,583-861N/A1,271N/A
12/31/20135,766-866N/A1,042N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat BHC de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.6% ).

Winst versus markt: Er wordt verwacht dat BHC de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat BHC binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van BHC ( 1.5% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van BHC ( 1.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van BHC naar verwachting over 3 jaar hoog zal zijn

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y